Take Five: A Psoriatic Arthritis Quiz

Author(s):

Andrew D. Bowser

See if you can correctly answer these 5 questions that cover biomarkers, the CASPAR criteria, and more.

We continue our series of quizzes on psoriatic arthritis (PsA) with this set of 5 questions covering biomarkers for the disease, nail lesions, differentiating PsA from rheumatoid arthritis, and more. Are you ready for a challenge? Get started with the first question below:

 

Question 1.

Elevations in which of the following biomarkers are confirmed to be diagnostic of psoriatic arthritis?

A. ITGβ5

B. M2BP

C. C-reactive protein (CRP)

D. M2BP plus CRP

E. None of the above


Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Related Content
US FDA logo in black over a white background. | Credit: US Food and Drug Administration
November 23rd 2024

FDA Approves Acoramidis (Attruby) for ATTR-CM

Patrick Campbell
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
November 22nd 2024

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying

Steven Levine, MD Dominic Sisti, PhD
Protein and Glycine in Allergens: Negative Correlation with Allergy Prevalence
November 22nd 2024

Protein and Glycine in Allergens: Negative Correlation with Allergy Prevalence

Tim Smith
Medical Ethics Unpacked:
November 22nd 2024

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy | Image Credit: US Food and Drug Administration
November 22nd 2024

FDA Issues CRL to Avacincaptad Pegol sNDA for Geographic Atrophy

Connor Iapoce
Esi Lamousé-Smith, MD, PhD | Credit: Johnson & Johnson
November 22nd 2024

J&J Submits sBLA for Guselkumab (Tremfya) Subcutaneous Induction Regimen in UC

Abigail Brooks, MA
© 2024 MJH Life Sciences

All rights reserved.